Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19129823 | 0.93 | KEAP1 (0.59) | KEAP1NFE2L2 | |
| SCHEMBL13532042 | 0.93 | KEAP1 (0.59) | KEAP1NFE2L2 | |
| SCHEMBL19129847 | 0.89 | KEAP1 (0.54) | KEAP1NFE2L2 | |
| SCHEMBL24473698 | 0.88 | KEAP1 (0.54) | KEAP1NFE2L2 | |
| SCHEMBL24473722 | 0.87 | KEAP1 (0.54) | KEAP1NFE2L2 | |
| SCHEMBL19146576 | 0.86 | KEAP1 (0.56) | KEAP1NFE2L2 | |
| SCHEMBL19129822 | 0.86 | KEAP1 (0.55) | KEAP1NFE2L2 | |
| SCHEMBL13532040 | 0.86 | KEAP1 (0.55) | KEAP1NFE2L2 | |
| SCHEMBL30892082 | 0.86 | KEAP1 (0.55) | KEAP1NFE2L2 | |
| SCHEMBL26859889 | 0.84 | KEAP1 (0.51) | KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307356-B2 | Method for producing mycosporine-like amino acid using microbes | THE KITASATO INSTITUTE (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20170202762-A1 | METHOD FOR PRODUCING MYCOSPORINE-LIKE AMINO ACID USING MICROBES | THE KITASATO INSTITUTE (JP) | 2017-07-20 | — | — | US | disclosed |
| US-20170202762-A1 | METHOD FOR PRODUCING MYCOSPORINE-LIKE AMINO ACID USING MICROBES | THE KITASATO INSTITUTE (JP) | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10307356-B2 | Method for producing mycosporine-like amino acid using microbes | CUTA, AADAT, MYC | KEAP1 1390/4885NFE2L2 2834/4885 |
| US-20170202762-A1 | METHOD FOR PRODUCING MYCOSPORINE-LIKE AMINO ACID USING MICROBES | CUTA, AADAT, MYC | KEAP1 1390/4885NFE2L2 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.